Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Mayo Clinic
Headquarters: Rochester, MN, United States of America
Website: http://www.mayoclinic.org
Year Founded: 1863
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 23, 2024
Finance
ATB’s €54M series A among largest ever in Belgium
BioCentury’s Financial Report also includes new biotech foundry Jupiter, and public equity fundings for Spyre, Cidara and Aclaris
BioCentury | Oct 18, 2024
Discovery & Translation
Making preclinical models more human-like
Ten new mouse and 3D cell models meant to better mimic human organ function or disease
BioCentury | Jul 8, 2024
Deals
Via $3.2B Morphic deal, Lilly gets oral integrin to compete in Entyvio’s class
Small molecule program, now in Phase II, could challenge injectable blockbuster; joins IBD drug Omvoh in pharma’s immunology arsenal
BioCentury | Jun 7, 2024
Finance
Venture Report: Australia’s Brandon Capital raises its largest fund yet
Plus VC rounds for ITM Isotope, Nucleus and Vilya
BioCentury | May 14, 2024
Management Tracks
Barrett to lead Pulse as CEO
Plus: Anumana hires Harry Palmin as CFO, and new SVP of regulatory at Nanoscope
BioCentury | May 3, 2024
Discovery & Translation
CAR T cells: Cancer, autoimmunity, and beyond?
ASGCT abstracts highlight applications for CAR Ts outside of cancer
BioCentury | May 2, 2024
Finance
Venture report: Rounds for psychedelic play Reunion, cancer company Delphia
Plus: Syndicate backs BridgeBio’s cancer spinout, AbCellera teams with investors to form asset-focused newcos, and more
BioCentury | Nov 21, 2023
Deals
Nov. 21 Quick Takes: Merck buying neurology play Caraway
Plus: Simcere takes Greater China rights to Connect’s IL-4R program, and updates from BeiGene, Ensem, J&J, Genmab, Alto, Ascendis and more
BioCentury | Nov 8, 2023
Management Tracks
Bertagnolli confirmed as NIH director
Plus: Filosi named CEO at Diaccurate, and updates from CIRM and City of Hope
BioCentury | Oct 31, 2023
Product Development
Digital endpoints could be the key to patient-focused drug development
Digital endpoints offer unambiguous promise, but who will take on the risks and challenges of developing them?
Items per page:
1 - 10 of 500